Toxicity study of oxalicumone A, derived from a marine-derived fungus Penicillium oxalicum, in cultured renal epithelial cells
Autor: | Weirong Li, Hao Chen, Jianbin Min, Kunbin Guo, Wei Zhao, Si Shi, Shuhua Qi, Xiangyu Wang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Cancer Research Cell human kidney-2 cells medicine.disease_cause Kidney Biochemistry 0302 clinical medicine Malondialdehyde Cytotoxicity bcl-2-Associated X Protein chemistry.chemical_classification Membrane Potential Mitochondrial Apoptosis Regulator Caspase 3 apoptosis Articles Penicillium oxalicum Cell biology mitochondria medicine.anatomical_structure Oncology Proto-Oncogene Proteins c-bcl-2 030220 oncology & carcinogenesis Molecular Medicine cytotoxicity oxalicumone A endocrine system Biology Nitric Oxide Cell Line 03 medical and health sciences Acetylglucosaminidase Genetics medicine Humans fas Receptor Molecular Biology Reactive oxygen species L-Lactate Dehydrogenase Cell growth Superoxide Dismutase Penicillium Epithelial Cells Molecular biology 030104 developmental biology chemistry Apoptosis Cell culture Chromones Reactive Oxygen Species Oxidative stress |
Zdroj: | Molecular Medicine Reports |
ISSN: | 1791-3004 1791-2997 |
Popis: | Oxalicumone A (POA), a novel dihydrothiophene-condensed chromone, was isolated from the marine-derived fungus Penicillium oxalicum. Previous reports demonstrated that POA exhibits strong activity against human carcinoma cells, thus it has been suggested as a bioactive anticancer agent. To research the toxic effect of POA on cultured normal epithelial human kidney-2 (HK-2) cells and evaluate its clinical safety, cell survival was evaluated by the Cell Counting Kit-8 assay and apoptosis was evaluated by Hoechst 33258 staining, flow cytometry, caspase-3 activity assay and western blotting. 2',7'-Dichlorofluorescin diacetate and JC-1 dye staining was used to evaluate reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP), respectively. The results indicated that POA inhibited HK-2 cell growth and promoted apoptosis, by increasing levels of Fas cell surface cell receptor and the B-cell lymphoma 2 associated protein X apoptosis regulator (Bax)/B-cell lymphoma 2 apoptosis regulator (Bcl-2) ratio. POA treatment also induced release of ROS and loss of MMP in HK-2 cells. Compared with untreated control, a significant decrease was also demonstrated in superoxide dismutase activity and glutathione content with POA treatment, accompanied by enhanced release of N-acetyl-beta-D-glucosaminidase, increased leakage of lactate dehydrogenase, increased malondialdehyde formation and increased release of nitric oxide. In conclusion, the present in vitro study revealed that POA exhibits antiproliferation activity on HK-2 cells, through stimulation of apoptosis and oxidative stress injury, which may be relevant to its clinical application. The present study may, therefore, offer valuable new information regarding the use of POA as a candidate novel antitumor drug for clinical use. |
Databáze: | OpenAIRE |
Externí odkaz: |